An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions
- 1 September 2017
- Vol. 35 (38) , 5172-5178
- https://doi.org/10.1016/j.vaccine.2017.07.101
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Plan of China (2016YFC1200904)
This publication has 39 references indexed in Scilit:
- Genome Sequence of Lassa Virus Isolated from the First Domestically Acquired Case in GermanyMicrobiology Resource Announcements, 2016
- Imported Case of Lassa Fever in Sweden With Encephalopathy and Sensorineural Hearing DeficitOpen Forum Infectious Diseases, 2016
- Lassa feverNursing2021, 2016
- As Ebola winds down, Lassa Fever reemerges yet again in West Africa.Journal of Infection in Developing Countries, 2016
- Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigsVaccine, 2011
- Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primatesPublished by Elsevier ,2008
- Properties of Replication-Competent Vesicular Stomatitis Virus Vectors Expressing Glycoproteins of Filoviruses and ArenavirusesJournal of Virology, 2004
- Towards a human Lassa fever vaccineReviews in Medical Virology, 2001
- Effective Vaccine for Lassa FeverJournal of Virology, 2000
- Lassa FeverNew England Journal of Medicine, 1986